vs

Side-by-side financial comparison of Arlo Technologies, Inc. (ARLO) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $141.3M, roughly 1.6× Arlo Technologies, Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 4.1%, a 15.3% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 16.2%). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 6.7%).

Arlo Technologies is an American company that makes wireless surveillance cameras. Prior to an initial public offering (IPO) on the New York Stock Exchange in August 2018, Arlo was a brand of such products by Netgear, which retained majority control after the IPO.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

ARLO vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.6× larger
ORGO
$225.6M
$141.3M
ARLO
Growing faster (revenue YoY)
ORGO
ORGO
+61.9% gap
ORGO
78.1%
16.2%
ARLO
Higher net margin
ORGO
ORGO
15.3% more per $
ORGO
19.4%
4.1%
ARLO
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
6.7%
ARLO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARLO
ARLO
ORGO
ORGO
Revenue
$141.3M
$225.6M
Net Profit
$5.8M
$43.7M
Gross Margin
46.4%
Operating Margin
3.3%
28.1%
Net Margin
4.1%
19.4%
Revenue YoY
16.2%
78.1%
Net Profit YoY
218.6%
469.5%
EPS (diluted)
$0.06
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARLO
ARLO
ORGO
ORGO
Q4 25
$141.3M
$225.6M
Q3 25
$139.5M
$150.9M
Q2 25
$129.4M
$101.0M
Q1 25
$119.1M
$86.7M
Q4 24
$121.6M
$126.7M
Q3 24
$137.7M
$115.2M
Q2 24
$127.4M
$130.2M
Q1 24
$124.2M
$110.0M
Net Profit
ARLO
ARLO
ORGO
ORGO
Q4 25
$5.8M
$43.7M
Q3 25
$6.9M
$21.6M
Q2 25
$3.1M
$-9.4M
Q1 25
$-835.0K
$-18.8M
Q4 24
$-4.9M
$7.7M
Q3 24
$-4.4M
$12.3M
Q2 24
$-11.6M
$-17.0M
Q1 24
$-9.6M
$-2.1M
Gross Margin
ARLO
ARLO
ORGO
ORGO
Q4 25
46.4%
Q3 25
40.5%
Q2 25
44.9%
Q1 25
44.3%
72.6%
Q4 24
36.9%
75.5%
Q3 24
35.2%
76.7%
Q2 24
36.8%
77.6%
Q1 24
38.1%
73.9%
Operating Margin
ARLO
ARLO
ORGO
ORGO
Q4 25
3.3%
28.1%
Q3 25
0.6%
13.7%
Q2 25
1.5%
-12.5%
Q1 25
-1.2%
-30.9%
Q4 24
-5.0%
8.1%
Q3 24
-4.0%
5.4%
Q2 24
-10.0%
-10.7%
Q1 24
-8.5%
-3.5%
Net Margin
ARLO
ARLO
ORGO
ORGO
Q4 25
4.1%
19.4%
Q3 25
4.9%
14.3%
Q2 25
2.4%
-9.3%
Q1 25
-0.7%
-21.7%
Q4 24
-4.0%
6.1%
Q3 24
-3.2%
10.7%
Q2 24
-9.1%
-13.1%
Q1 24
-7.8%
-1.9%
EPS (diluted)
ARLO
ARLO
ORGO
ORGO
Q4 25
$0.06
$0.31
Q3 25
$0.06
$0.11
Q2 25
$0.03
$-0.10
Q1 25
$-0.01
$-0.17
Q4 24
$-0.05
$0.05
Q3 24
$-0.04
$0.09
Q2 24
$-0.12
$-0.13
Q1 24
$-0.10
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARLO
ARLO
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$146.4M
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$127.8M
$300.1M
Total Assets
$310.5M
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARLO
ARLO
ORGO
ORGO
Q4 25
$146.4M
$93.7M
Q3 25
$86.0M
$63.7M
Q2 25
$71.2M
$73.1M
Q1 25
$84.0M
$110.0M
Q4 24
$82.0M
$135.6M
Q3 24
$77.0M
$94.3M
Q2 24
$62.9M
$89.9M
Q1 24
$62.1M
$88.6M
Total Debt
ARLO
ARLO
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
ARLO
ARLO
ORGO
ORGO
Q4 25
$127.8M
$300.1M
Q3 25
$129.2M
$255.1M
Q2 25
$118.3M
$233.2M
Q1 25
$103.4M
$242.9M
Q4 24
$100.9M
$262.9M
Q3 24
$96.9M
$278.5M
Q2 24
$99.3M
$263.5M
Q1 24
$99.9M
$278.0M
Total Assets
ARLO
ARLO
ORGO
ORGO
Q4 25
$310.5M
$598.7M
Q3 25
$350.9M
$509.8M
Q2 25
$319.7M
$461.1M
Q1 25
$296.6M
$467.4M
Q4 24
$298.4M
$497.9M
Q3 24
$312.4M
$446.3M
Q2 24
$295.8M
$443.2M
Q1 24
$289.8M
$458.5M
Debt / Equity
ARLO
ARLO
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARLO
ARLO
ORGO
ORGO
Operating Cash FlowLast quarter
$19.8M
$39.4M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
3.43×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARLO
ARLO
ORGO
ORGO
Q4 25
$19.8M
$39.4M
Q3 25
$19.2M
$3.1M
Q2 25
$8.8M
$-32.9M
Q1 25
$30.9M
$-19.9M
Q4 24
$6.7M
$10.9M
Q3 24
$18.4M
$8.7M
Q2 24
$6.5M
$4.7M
Q1 24
$19.8M
$-10.2M
Free Cash Flow
ARLO
ARLO
ORGO
ORGO
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$28.1M
$-23.6M
Q4 24
$5.6M
$7.6M
Q3 24
$17.4M
$6.1M
Q2 24
$6.2M
$2.9M
Q1 24
$19.4M
$-12.4M
FCF Margin
ARLO
ARLO
ORGO
ORGO
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
23.6%
-27.2%
Q4 24
4.6%
6.0%
Q3 24
12.6%
5.3%
Q2 24
4.8%
2.2%
Q1 24
15.7%
-11.3%
Capex Intensity
ARLO
ARLO
ORGO
ORGO
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
2.4%
4.2%
Q4 24
0.9%
2.7%
Q3 24
0.7%
2.2%
Q2 24
0.2%
1.4%
Q1 24
0.3%
2.0%
Cash Conversion
ARLO
ARLO
ORGO
ORGO
Q4 25
3.43×
0.90×
Q3 25
2.79×
0.14×
Q2 25
2.83×
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARLO
ARLO

Subscriptions And Services$89.4M63%
Products$51.9M37%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons